Sep 10, 2007
2:1
For every share held, investors received 2. The price per share adjusted from $708.10 to $354.05.
The split itself did not change the total investment value.
Glenmark Pharmaceuticals Limited (BSE:GLENMARK) operates in the Pharmaceuticals: major industry.
Glenmark Pharmaceuticals Limited company overviewGlenmark Pharmaceuticals Limited's most recent stock split was on September 10, 2007. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Glenmark Pharmaceuticals Limited (BSE:GLENMARK) has split its stock 3 times: a 5-for-1 split on October 23, 2003, a 2-for-1 split on March 4, 2005, and a 2-for-1 split on September 10, 2007.
Glenmark Pharmaceuticals Limited has split its stock 3 times. This history records 3 forward splits between October 23, 2003 and September 10, 2007.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Glenmark Pharmaceuticals Limited's 2-for-1 split on September 10, 2007, every share became 2 shares.
Glenmark Pharmaceuticals Limited has not announced a new split in our records. Its most recent split was on September 10, 2007, 19 years ago. Companies announce splits in advance, and any new BSE:GLENMARK split will appear on this page.
Already premium?